Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use JINTELI® safely and effectively. See full prescribing information for JINTELI®. JINTELI® (norethindrone acetate and ethinyl estradiol tablets), for oral use Initial U.S. Approval: 1968
Medication labelWhy this: Advisory · dailymed-prescription
Limitation of Use When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.
- generic_name
- norethindrone acetate and ethinyl estradiol
- product_names
- norethindrone acetate and ethinyl estradiol
- ndc
- 0093-3122, 0093-3122-98, 0093-3122-28, 0093-3122-42
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en